New York, Thursday, December 15, 2016 - According to PwC’s Health Research Institute (HRI), 2017 will be a year dominated by the continued shift toward value within healthcare as the industry adapts to a new era under the administration of President-elect Donald J. Trump. Traditional health organizations and new entrants will need to balance the uncertainty of the new administration’s approach to healthcare with the continued opportunities being created by forces greater than politics.
In its annual report, “Top Health Industry Issues of 2017,” released today, PwC’s HRI highlights the top 10 forces that are expected to have the most impact on the industry in the coming year. Leveraging results from a survey of 1,750 US consumers and interviews with health industry leaders, the report outlines three main strategies key healthcare players are expected to use to address the shift to value:
“Today we have a health system that is more connected, transparent and patient-centric than ever before. Over the course of the past decade, the healthcare industry has witnessed significant improvements, but also consistent challenges in the New Health Economy,” said Kelly Barnes, PwC US Health Industries leader. “There is still work to be done to improve the consumer experience and affordability even as a new presidential administration starts to make their mark on the health system. Our prescription for the industry--double down on more innovation, new collaborations and the shift to value-based care."
Issue #1: Under a new administration, the fate of the ACA remains unclear
Issue #2: Pharma’s new strategic partner? Patients
Issue #3: Easing the training wheels off value-based payment
Issue #4: Insert your card here for healthcare
Issue #5: Paging Dr. Drone: It’s time to prepare for emerging technologies
Issue #6: The battle against infectious diseases sparks invention
Issue #7: Rx cauliflower: Nutrition moves to population health
Issue #8: Putting the brakes – gently – on drug prices
Issue #9: A year of new partnerships and collaborations
Issue #10: Preparing medical students for work in a value-based world
For the full report and graphics illustrating each issue, click here.
 Ehrhardt and Behner, “Digitization in pharma: Gaining an edge in operations.”
 Greg Trotter, “Dietitian on aisle four: Grocery stores are calling in health experts,” Chicago Tribune, Nov. 10, 2016, http://www.chicagotribune.com/business/ctgrocery-store-dietitians-0501-biz-20160429-story.html.
PwC’s Health Research Institute (www.pwc.com/hri) provides new intelligence, perspectives, and analysis on trends affecting all health-related industries. The Health Research Institute helps executive decision makers navigate change through primary research and collaborative exchange. Its views are shaped by a network of professionals with executive and day-to-day experience in the health industry. HRI research is independent and not sponsored by businesses, government, or other institutions.
PwC’s Health Industries Group (www.pwc.com/us/healthindustries) is a leading advisor to public and private organizations across the health industries, including healthcare providers, pharmaceuticals, health and life sciences, payers, employers, academic institutions and non-health organizations with significant presence in the health market. Follow PwC Health Industries at @PwCHealth.
At PwC, our purpose is to build trust in society and solve important problems. We’re a network of firms in 157 countries with more than 223,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.
PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.
© 2016 PwC. All rights reserved.